`
Monday, 26 June 2017

Drug Discovery News

  • Self monitoring diabetes market to reach $358 mn

    Drug Discovery |  Analysis | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2013

    Singapore: Three quarters of the population of China and India are diabetic. This translates to a patient pool of nearly 200 million for the self monitoring of blood glucose (SMBG) market. ...Read more

  • PeptiDream, Teijin to co-discover peptide-based therapeutics

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 30 Sep, 2015

    Tokyo: PeptiDream Inc., a Tokyo-based biopharmaceutical company, has signed a multi-target discovery and optimization collaboration agreement with Teijin Pharma Limited, Tokyo, Japan. The ...Read more

  • 3SBio, Alteogen to develop antibody for metastatic cancer

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 13 Oct, 2015

    Singapore: 3SBio, China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, has entered into an exclusive licensing deal ...Read more

  • Roivant acquires GSK's Alzheimer's drug candidate

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 30 Dec, 2014

    Singapore: US based Roivant Neurosciences, a biopharmaceutical company engaged in the development and commercialization of late-stage drug candidates for neurologic diseases, has acquired G...Read more

  • Korea's ImmunoMet raises $5.2 mn

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2016

    Singapore: Korea based ImmunoMet Therapeutics, a biotechnology company developing innovative drugs for the treatment of cancer, has raised $5.2 million in a Series A financing led by Mirae ...Read more

  • Cellworks, AstraZeneca join hands for TB research

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 03 Jul, 2012

    Bangalore: AstraZeneca and Cellworks have announced a collaboration, to speed the design of novel combination therapies for the treatment of drug-sensitive and resistant tuberculosis. This ...Read more

  • Dengue can soon be treated!

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 11 Sep, 2015

    Singapore: Researchers from the University of Queensland in Australia have identified that existing drugs could be repurposed to create a world-first treatment for dengue fever. The team s...Read more

  • Genticel secures patent for a targeted therapy for cancer

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 08 Sep, 2015

    Singapore: Genticel, a clinical-stage biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), has been granted a new p...Read more

  • Hong Kong approves asthma drug flutiform

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 11 Nov, 2013

    ‎Singapore: Mundipharma, an Asian pharmaceutical company, has launched Flutiform (fluticasone propionate/formoterol fumarate), a new combination therapy for the maintenance treatment ...Read more

  • FDA nod for Novartis eyecare firm's glaucoma drug

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 22 Apr, 2013

    Singapore: Alcon, the global leader in eye care and a division of Novartis, has recieved US FDA approval for Simbrinza suspension, indicated for the reduction of elevated intraocular pressu...Read more

  • FDA stamps Merck's Hep C drug as breakthough therapy

    Drug Discovery |  Regulatory | By BioSpectrum Bureau | 0 Comment | 09 Apr, 2015

    Singapore: Merck's grazoprevir/elbasvir, an investigational single tablet regimen for the treatment of chronic hepatitis C virus (HCV) infection, has received breakthrough therapy designati...Read more

  • Astellas, FibroGen start CKD anemia trial in Japan

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2013

    Singapore: Japan-based Astellas Pharma and US-based FibroGen initiated a phase II clinical study in Japan of ASP1517/FG-4592 for the treatment of anemia associated with chronic kidney disea...Read more

  • Aussie firm to begin human trial of cancer detecting antibody

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 23 Oct, 2015

    Singapore: Australian immuno-oncology company, Minomic International, is set to launch the first human study of its novel monoclonal antibody technology as an imaging agent to detect prosta...Read more

  • USFDA approves 'Female Viagra'

    Drug Discovery |  News | By Raj Gunashekar | 0 Comment | 19 Aug, 2015

    US-based Sprout Pharmaceuticals gained USFDA's approval for Addyi, whose chemical name is Flibanserin, created to enhance sex drive in premenopausal women or women suffering from hypoactive...Read more

  • BioDiem protozoan drug to get Japanese patent

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 27 May, 2013

    Singapore: Australian infectious disease therapy and vaccine development company, BioDiem, has received allowance of Japanese patent for its novel antimicrobial compound, BDM-I. The patent...Read more

  • Gilead submits NDA for cancer drug Idelalisib

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 13 Sep, 2013

    Singapore: Gilead Sciences has submitted a new drug application (NDA) to the US FDA for the approval of Idelalisib, an investigational, targeted, oral inhibitor of PI3K delta, for the treat...Read more

  • TWi's drug gets rare disease drug designation in Taiwan

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 11 Mar, 2015

    Singapore: Taiwan based TWi Pharmaceutical's drug candidate AC-203 has received designation of rare disease drug by Taiwan FDA to treat Epidermolysis Bullosa Simplex (EBS), and is eligible ...Read more

  • Singapore scientists engineer human stem cells

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 09 Dec, 2013

    Singapore: A*Star's Genome Institute of Singapore (GIS) have successfully converted human embryonic stem cells (hESCs) cultured in the laboratory to a state that is closer to the cells foun...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls